Delivery Order SPE2DB22D6029-SPE2DB24FU0RE
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,885.00 firm fixed-price delivery order is for the supply of 4566278680 ! ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a medical product used for pain management. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,571.90, is for the delivery of 400 mg/200 mL Ropivacaine 0.2% injection. This is a firm fixed-price delivery order contract with a completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,730.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4565221300 - Ropivacaine 0.2% 200 mg/100 ml, a pharmaceutical product, to support military treatment facilities and programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen, as a major...
This federal contract award SPE2DX15D3404|SPE2DX24F1BGC was issued to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $1,958.12 firm fixed-price delivery order is for the supply of 4564340078 - Ropivacaine 0.2% 400 mg/200 ml, a prescription medication, to the Department of Defense's Medical Supply Chain. The award has an ultimate completion date of April 22, 2024 and was issued on April 19, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,581.68 Firm Fixed Price Delivery Order is for the supply of 200 mg/100 mL vials of the anesthetic drug Ropivacaine 0.2%. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,877.64, is for the delivery of 4562519583 ROPIVACAINE 0.2% 400 MG/200 ML 200ML medical supplies. The contract has a firm fixed price pricing type and an ultimate completion date of October 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract...
This federal contract award, identified as SPE2DX15D1053|SPE2DX25F6HTR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,246.74 firm fixed-price delivery order is for the procurement of 400 mg/200 mL ropivacaine 0.2% solution, a pain management medication. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FWZ59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565856860 ! ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $3,563.88, and an ultimate completion date of September 19, 2024. This appears to be a delivery order contract, and there is no set-aside designation...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $8,459.74 from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of pharmaceutical products and medical supplies. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,572.68, is a Firm Fixed Price Delivery Order contract to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a period of performance ending on May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...